Physician profile
Victor Amato
NPI 1053325076
$1,906.89
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $803 · 2020: $998 · 2021: $107.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $898.58 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $407.81 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $107.67 | 2019-2021 | |
| Janssen Biotech, INC. | $72.49 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $72.46 | 2019-2020 | |
| Intercept Pharmaceuticals, INC. | $56.91 | 2019-2020 | |
| Redhill Biopharma INC. | $43.98 | 2020 | |
| Allergan, INC. | $42.91 | 2019-2020 | |
| Braintree Laboratories, INC. | $35.84 | 2019 | |
| Nestle Healthcare Nutrition INC. | $33.57 | 2020-2021 | |
| Gilead Sciences, INC. | $31.44 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $26.08 | 2019-2020 | |
| Daiichi Sankyo INC. | $17.09 | 2020 | |
| Pfizer INC. | $16.12 | 2019 | |
| Evoke Pharma, INC. | $15.70 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $14.37 | 2020 | |
| Shionogi INC | $13.87 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victor Amato listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.